AML/MDS
Clinical trials for AML/MDS explained in plain language.
Never miss a new study
Get alerted when new AML/MDS trials appear
Sign up with your email to follow new studies for AML/MDS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat blood cancers: experimental combo targets relapsed AML and MDS
Disease control Recruiting nowThis early-phase study tests a new drug called danvatirsen, first alone and then combined with venetoclax, in 38 adults whose acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) have returned or not responded to standard treatments. The goal is to see if the drug is s…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated May 17, 2026 02:57 UTC
-
Engineered immune cells take aim at tough childhood leukemias
Disease control Recruiting nowThis early-phase trial tests a new treatment called CD123-CAR T cells for children and young adults up to age 21 with certain blood cancers (AML, MDS, ALL, or BPDCN) that have come back or not responded to standard therapy. The treatment involves collecting the patient's own immu…
Matched conditions: AML/MDS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 06, 2026 16:03 UTC